Johnson David Michael - Insider Non-Derivative Transactions at Zentalis Pharmaceuticals, Inc. (ZNTL) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 21, 2024, Johnson David Michael's relationship to Zentalis Pharmaceuticals, Inc. (ZNTL) is Director, and currently has 192,818 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ZNTL insiders.
Data Source: SEC.
Johnson David Michael - Insider Non-Derivative Transactions of ZNTL Common Stock
Johnson David Michael - Insider Non-Derivative Transactions at ZNTL
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 22, 2024 | Acquisition -- (Common Stock) | 48429 | 0 | 192818 |
| Nov 11, 2023 | P -- (Common Stock) | 17000 | 9.88 | 144389 |
| Jun 17, 2023 | Acquisition -- (Common Stock) | 19059 | 0 | 127389 |